CIK 0001544227 · Non-accelerated filer<br>Smaller reporting company
Tempest Therapeutics, Inc.
Sign in to watch- Ticker
- TPST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 451472564
- Phone
- 415-798-8589
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 400, BRISBANE, CA, 94005
- Former names
- Millendo Therapeutics, Inc., OvaScience, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-04 | Maestas Nicholas VP of Strategy and Finance | Grant or award · Stock Option (Right to Buy) | +19,500 | 19,500 | ||
| 2022-01-04 | Whiting Samuel Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +29,000 | 29,000 | ||
| 2022-01-04 | Brady Stephen R Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +94,500 | 94,500 | ||
| 2022-01-04 | Dubensky Thomas W. President | Grant or award · Stock Option (Right to Buy) | +53,100 | 53,100 | ||
| 2021-09-21 | RAAB MICHAEL Director | Grant or award · Stock Option (Right to Buy) | +6,635 | 6,635 | ||
| 2021-08-06 | Simantov Ronit Director | Grant or award · Stock Option (Right to Buy) | +6,635 | 6,635 | ||
| 2021-07-12 | Maestas Nicholas VP of Strategy and Finance | Grant or award · Stock Option (Right to Buy) | +23,225 | 23,225 | ||
| 2021-07-01 | NICHOL GEOFFREY Director | Grant or award · Stock Option (Right to Buy) | +6,635 | 6,635 | ||
| 2021-07-01 | Pellizzari Christine A Director | Grant or award · Stock Option (Right to Buy) | +6,635 | 6,635 | ||
| 2021-07-01 | Woiwode Thomas Director | Grant or award · Stock Option (Right to Buy) | +6,635 | 6,635 | ||
| 2021-07-01 | Xu Stella Director | Grant or award · Stock Option (Right to Buy) | +6,635 | 6,635 | ||
| 2021-07-01 | Xu Stella Director | Grant or award · Stock Option (Right to Buy) | +6,635 | 6,635 | ||
| 2021-07-01 | Woiwode Thomas Director | Grant or award · Stock Option (Right to Buy) | +6,635 | 6,635 | ||
| 2021-07-01 | NICHOL GEOFFREY Director | Grant or award · Stock Option (Right to Buy) | +6,635 | 6,635 | ||
| 2021-07-01 | Pellizzari Christine A Director | Grant or award · Stock Option (Right to Buy) | +6,635 | 6,635 | ||
| 2021-06-25 | Whiting Samuel Chief Medical Officer | Grant or award | +201 | 201 | ||
| 2021-06-25 | Whiting Samuel Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +61,945 | 61,945 | ||
| 2021-06-25 | Whiting Samuel Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +3,018 | 3,018 | ||
| 2021-06-25 | Whiting Samuel Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +540,231 | 540,231 | ||
| 2021-06-25 | Xu Stella Director | Grant or award | +579,710 | 579,710 |
Page 4 of 6 · 119 trades